Skip to main content
main-content

Diabetes complications and comorbidities: Nephropathy

Interactive patient case study

Renal complications in diabetic ketoacidosis

Renal complications in diabetic ketoacidosis

This 15-minute case presents likely causes of renal complications in diabetic ketoacidosis and explains how to identify the signs and symptoms of renal complications to ensure early initiation of appropriate treatment.

Get more on: Diabetic ketoacidosis | Pediatric diabetes | Nephropathy

medwireNews editor's pick

DECLARE-TIMI 58 supports CV benefits of SGLT2 inhibitor class

New Content Item

The results of the DECLARE-TIMI 58 trial show a broadly positive effect of dapagliflozin on cardiovascular outcomes, especially heart failure, in patients with type 2 diabetes.

medwireNews editor's pick

Real-world bariatric surgery data show microvascular protection

Surgical tools

Obese patients with type 2 diabetes who undergo bariatric surgery achieve large reductions in their risk for microvascular complications, shows a real-world study.

Journal article

Chronic kidney disease-induced insulin resistance: Current state of the field

Kidneys and urinary bladder (illustration)

This review will evaluate mechanisms responsible for chronic kidney disease-induced insulin resistance and therapies currently available [read more].
Dave N, Wu J, Thomas S. Curr Diab Rep 2018; 18: 44. doi: 10.1007/s11892-018-1010-8

Get more on:  Diabetic complications | Type 1 diabetes | Type 2 diabetes

Journal article

Successful management of poorly controlled type 2 diabetes with multidisciplinary neurobehavioral rehabilitation: A case report and review

Smiling doctors

We present one successful case that demonstrates a significantly beneficial effect of physical exercise and lifestyle intervention in the management of type 2 diabetes mellitus [read more].
Deng Z et al. Diabetes Ther 2018. doi: 10.1007/s13300-018-0448-7

Get more on: Type 2 diabetes | Physical activity | Lifestyle interventions​​​​​​​

Journal article

Prevalence and incidence of complications at diagnosis of T2DM and during follow-up by BMI and ethnicity: A matched case–control analysis

Diverse group holding 'diabetes'

We estimate the risk of developing long-term major cardiovascular and renal complications in relation to levels of body mass index in a population of White European, African-Caribbean, and South Asian patients with type 2 diabetes mellitus [read more].
Owusu Adjah ES et al. Cardiovasc Diabetol 2018; 17: 70. doi: 10.1186/s12933-018-0712-1

Get more on: Type 2 diabetes | Diabetes in specific populations | Diabetic complications

medwireNews editor's pick

Renal risk associated with intensive BP treatment in type 2 diabetes

Blood pressure

Research shows that intensive blood pressure control increases the risk for new-onset chronic kidney disease, particularly in patients with type 2 diabetes, creating a potential treatment dilemma.

Ask the expert

Diabetes and blood pressure in the elderly: Which medications to use when; tips for achieving target

Ask the expert: Hypertension and diabetes - What medications can I use?

Editorial Board member Jay Shubrook follows up with treatment individualization specialist David Strain on the treatment challenges presented by older adults, and the implications for tailoring hypertension therapy in this diverse population [watch the video 11:08].

Get more on: Diabetic complications | Older adults | Medications

Ask the expert

What are the current recommendations for managing high blood pressure in diabetes patients?

Ask the expert: Hypertension and diabetes -  What are the current recommendations

Editorial Board member Jay Shubrook and lead author on the American Diabetes Association’s (ADA) 2017 Position Statement on diabetes and hypertension, Ian de Boer, summarize key updates to the recommendations for practitioners in the United States [watch the video 11:32].

Get more on: Type 1 diabetes | Type 2 diabetes | Cardiovascular disease | Guidelines

Expert opinion editorial

Metformin: What is new with this old medication?

medication capsule

With the arrival of slow-release formulations of metformin and the relaxation of guidelines concerning its use in patients with kidney disease, Carol Wysham explains how the population of patients who might benefit from this medication has expanded [read more].

Get more on: Type 2 diabetes | MetforminMedications | Expert opinion

medwireNews

01-09-2019 | Nephropathy | News

Albuminuria backed as kidney disease treatment response marker

The results of two individual patient data meta-analyses support albuminuria as a surrogate marker of treatment response in patients with chronic kidney disease, particularly those with high baseline albuminuria.

11-22-2018 | Nephropathy | News

International variation in ESRD, non-ESRD deaths in type 1 diabetes highlighted

The risk for end-stage renal disease is high among patients with type 1 diabetes and advanced nephropathy but varies by country, shows an analysis of cohorts from Finland, France, Denmark, and the USA.

11-14-2018 | Nephropathy | News

Ischemic heart disease biggest threat to type 1 diabetes patients after kidney transplant

Kidney transplantation greatly reduces mortality risk in people with type 1 diabetes and end-stage renal disease, but premature death from ischemic heart disease remains common, report researchers.

Interactive patient case study

12-21-2018 | Ketoacidosis | Case study

Renal complications in diabetic ketoacidosis

Develop and test your knowledge on the renal complications associated with diabetic ketoacidosis through this practical example and self-assessment authored by Professor Francesco Chiarelli. This 15-minute case presents likely causes of renal complications in diabetic ketoacidosis and explains how to identify the signs and symptoms of renal complications to ensure early initiation of appropriate treatment.

Themed collections

06-25-2018 | SGLT2 inhibitors | Themed collection | Collection

Sodium-glucose cotransporter-2 inhibitors in type 2 diabetes

An updated collection of articles focusing on the mechanism of action and clinical use of sodium-glucose cotransporter-2 inhibitors in patients with diabetes.

Journal articles and book chapters

11-08-2018 | Cardiovascular disorders | Review | Article

The evolving role of the cardiologist in the management of type 2 diabetes

Chilton RJ et al. Curr Diab Rep 2018; 18: 144. doi: 10.1007/s11892-018-1114-1

10-23-2018 | Complications | Article

Validation of time in range as an outcome measure for diabetes clinical trials

Beck RW et al. Diabetes Care 2018: dc181444. doi: 10.2337/dc18-1444

09-08-2018 | Nephropathy | Review | Article

Metabolic abnormalities in diabetes and kidney disease: Role of uremic toxins

Koppe L, Fouque D, Soulage CO. Curr Diab Rep 2018; 18: 97. doi: 10.1007/s11892-018-1064-7

08-15-2018 | Nephropathy | Review | Article

Inpatient glycemic management in the setting of renal insufficiency/failure/dialysis

Iyengar R, Franzese J, Gianchandani R. Curr Diab Rep 2018; 18: 75. doi: 10.1007/s11892-018-1044-y

Guidelines

A convenient single access point, providing diabetes professionals with links to a comprehensive set of clinical practice guidelines from a wide range of relevant organizations.

Slides

Downloadable PowerPoint slide sets containing a variety of high-quality images and illustrations from Springer Nature’s library of published figures.

Practice tips

Practical information, guidance, and helpful resources for diabetes healthcare providers. Comprised of practical approaches, case studies, and more.

Themed collections

Compendia of selected, recently published, free full-text journal and book content from Springer Nature and other publishers on a particular topic within diabetes management, as recommended by our Editorial Board.

Independent Medical Education

Educational programs building upon the most current research and professional practice recommendations, with the aim of enabling more efficient diagnosis, optimizing treatment, and improving patient outcomes.

image credits